| 000 | 01482 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516013754.0 | ||
| 264 | 0 | _c20110307 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1549-490X | ||
| 024 | 7 |
_a10.1634/theoncologist.2010-S4-42 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLencioni, Riccardo | |
| 245 | 0 | 0 |
_aTreatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? _h[electronic resource] |
| 260 |
_bThe oncologist _c2010 |
||
| 300 |
_a42-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzenesulfonates _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aChemoembolization, Therapeutic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPalliative Care |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aPyridines _xadministration & dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aStandard of Care |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChen, Xiao-Ping | |
| 700 | 1 | _aDagher, Lucy | |
| 700 | 1 | _aVenook, Alan P | |
| 773 | 0 |
_tThe oncologist _gvol. 15 Suppl 4 _gp. 42-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1634/theoncologist.2010-S4-42 _zAvailable from publisher's website |
| 999 |
_c20408132 _d20408132 |
||